Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: A systematic literature review

International Journal of Clinical Practice

Volumn 66, Issue 11, 2012, Pages 1056-1078

  Tsai, H H ^a,b   Lin, H W ^a,b,c   Simon Pickard, A ^c   Tsai, H Y ^a,b   Mahady, G B ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGRAPHIS PANICULATA EXTRACT; BAICALIN; CAFFEINE; CALCIUM; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIGOXIN; FEXOFENADINE; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INSULIN; IRON; KAVA; MAGNESIUM; METRONIDAZOLE; MIDAZOLAM; NIFEDIPINE; OMEPRAZOLE; ROSUVASTATIN; SILYMARIN; THEOPHYLLINE; TICLOPIDINE; TRAZODONE; UNINDEXED DRUG; WARFARIN; YOHIMBINE;

AREA UNDER THE CURVE; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERACTION; DRUG POTENTIATION; ECHINACEA; GASTROINTESTINAL DISEASE; HEALTH CARE PERSONNEL; HUMAN; KIDNEY DISEASE; LINSEED; MAXIMUM PLASMA CONCENTRATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; UROGENITAL TRACT DISEASE;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HERB-DRUG INTERACTIONS; HUMANS; PLANT PREPARATIONS; RATS; RESEARCH DESIGN;

EID: 84867531046     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.03008.x     Document Type: Review

References (121)

1. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF,. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004; 160: 339-49. (Pubitemid 39045265)
2. Timbo BB, Ross MP, McCarthy PV, Lin CT,. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc 2006; 106: 1966-74. (Pubitemid 44779443)
3. Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R,. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc 2008; 108: 483-94. (Pubitemid 351288619)
4. Gardiner P, Graham RE, Legedza AT, Eisenberg DM, Phillips RS,. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006; 166: 1968-74. (Pubitemid 44537176)
5. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA,. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287: 337-44. (Pubitemid 34251967)
6. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE,. Americans' views on the use and regulation of dietary supplements. Arch Intern Med 2001; 161: 805-10. (Pubitemid 32225388)
7. Palmer ME, Haller C, McKinney PE, et al., Adverse events associated with dietary supplements: an observational study. Lancet 2003; 361: 101-6. (Pubitemid 36092013)
8. Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C,. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 2007; 27: 1237-47. (Pubitemid 47339121)
9. Mehta DH, Gardiner PM, Phillips RS, McCarthy EP,. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 2008; 14: 1263-9.
10. Kemper KJ, Amata-Kynvi A, Dvorkin L, et al., Herbs and other dietary supplements: healthcare professionals' knowledge, attitudes, and practices. Altern Ther Health Med 2003; 9: 42-9. (Pubitemid 36576279)
11. Suchard JR, Suchard MA, Steinfeldt JL,. Physician knowledge of herbal toxicities and adverse herb-drug interactions. Eur J Emerg Med 2004; 11: 193-7.
12. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD,. Herb-drug interactions: an evidence based approach. Curr Med Chem 2004; 11: 1513-25. (Pubitemid 38735793)
13. Silverstein DD, Spiegel AD,. Are physicians aware of the risks of alternative medicine? J Community Health 2001; 26: 159-74. (Pubitemid 33745833)
14. Zeolla MM, Cerulli J,. Use of and familiarity with dietary supplement information references by practicing pharmacists. J Am Pharm Assoc 2008; 48: 401-4.
15. Miller LG, Hume A, Harris IM, et al., White paper on herbal products. American College of Clinical Pharmacy. Pharmacotherapy 2000; 20: 877-91.
16. Cassileth BR,. Herb-Drug Interactions in Oncology. Lewiston, NY: BC Decker, Inc., 2003.
17. Gaby AR,. A-Z Guide to Drug-Herb-Vitamin Interactions. New York: Three Rivers Press, 2006.
18. Mahady GB,. Botanical Dietary Supplements: Quality, Safety and Efficacy. Lisse, The Netherlands: Swets & Zeitlinger Publishers, 2001.
19. Mason P,. Dietary Supplements. London: Pharmaceutical Press, 2001.
20. Tatro DS,. Drug Interaction Facts. Saint Louis: Wolters Kluwer Health/Facts & Comparisons, 2010.
21. Ulbricht CE,. Natural Standard Herbs & Supplement Reference: Evidence-Based Clinical Review. St Louis, MO: Mosby/Elsevier, 2005.
22. National Center for Complementary and Alternative Medicine. Herbs at a Glance. http://nccam.nih.gov/health/herbsataglance.htm (accessed October 2011).
23. Office of Dietary Supplements. Dietary Supplement Fact Sheets. http://ods.od.nih.gov/factsheets/list-all/ (accessed October 2011).
24. Dietary Supplement Health and Education Act of 1994. Public Law 103-417 1994. http://ods.od.nih.gov/about/dshea-wording.aspx (accessed February 2011).
25. Ernst E,. Herbal medicinal products during pregnancy: are they safe? Br J Obstet Gynaecol 2002; 109: 227-35. (Pubitemid 37329295)
26. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011. http://www.whocc.no/atc-ddd-index/ (accessed December 2011).
27. MICROMEDEX® 1.0 (Healthcare Series). Interaction Database. http://www.thomsonhc.com/hcs/librarian/ND-T/HCS/ND-PR/Main/CS/A304ED/ DUPLICATIONSHIELDSYNC/95C0EB/ND-PG/PRIH/ND-B/HCS/ND-P/Main/PFActionId/hcs. Interactions.FindDrugInteractions (accessed November 2011).
28. Natural Medicines Comprehensive Database. Natural Product/Drug Interaction Checker. http://naturaldatabase.therapeuticresearch.com/nd/Search. aspx?s=ND&cs=&pt=7&rli=1&sh= (accessed December 2011).
29. Goldman L, Ausiello DA, Arend W, Armitage JO,. Cecil Medicine: Expert Consult. Philadelphia, PA: Saunders Elsevier, Inc., 2007.
30. Ernst E,. Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 2000; 56: 523-4.
31. Fugh-Berman A,. Herb-drug interactions. Lancet 2000; 355: 134-8. (Pubitemid 30068565)
32. McIntyre M,. A review of the benefits, adverse events, drug interactions, and safety of St. John's Wort (Hypericum perforatum): the implications with regard to the regulation of herbal medicines. J Altern Complement Med 2000; 6: 115-24. (Pubitemid 30226612)
33. Semaan N,. Integration of complementary disciplines into the oncology clinic. Part III. Herbal medicine-drug interactions: the role of the pharmacist. Curr Probl Cancer 2000; 24: 213-22.
34. Barone GW, Gurley BJ, Ketel BL, Abul-Ezz SR,. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001; 71: 239-41. (Pubitemid 32126106)
35. Fugh-Berman A, Ernst E,. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587-95.
36. Izzo AA, Ernst E,. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61: 2163-75. (Pubitemid 34074799)
37. Markowitz JS, DeVane CL,. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). Psychopharmacol Bull 2001; 35: 53-64.
38. Rogers EA, Gough JE, Brewer KL,. Are emergency department patients at risk for herb-drug interactions? Acad Emerg Med 2001; 8: 932-4. (Pubitemid 32843803)
39. Block KI, Gyllenhaal C,. Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integr Cancer Ther 2002; 1: 83-9. (Pubitemid 37101542)
40. Dergal JM, Gold JL, Laxer DA, et al., Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 2002; 19: 879-86. (Pubitemid 35440606)
41. Ly J, Percy L, Dhanani S,. Use of dietary supplements and their interactions with prescription drugs in the elderly. Am J Health Syst Pharm 2002; 59: 1759-62. (Pubitemid 35033914)
42. Lyons TR,. Herbal medicines and possible anesthesia interactions. AANA J 2002; 70: 47-51. (Pubitemid 34141962)
43. Myers SP,. Interactions between complementary medicines and warfarin. Aust Prescr 2002; 25: 54-6. (Pubitemid 34601882)
44. Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD,. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 6: 414-20. (Pubitemid 34701348)
45. Buehler BA,. Interactions of herbal products with conventional medicines and potential impact on pregnancy. Birth Defects Res B Dev Reprod Toxicol 2003; 68: 494-5. (Pubitemid 38055973)
46. Chavez ML, Jordan MA, Chavez PI,. Evidence-based drug-herbal interactions. Life Sci 2006; 78: 2146-57.
47. Williamson EM,. Drug interactions between herbal and prescription medicines. Drug Saf 2003; 26: 1075-92. (Pubitemid 38021390)
48. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW,. Interactions of herbs with cytochrome P450. Drug Metab Rev 2003; 35: 35-98. (Pubitemid 36249785)
49. Gurley BJ, Gardner SF, Hubbard MA, et al., In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004; 5: 428-40. (Pubitemid 39469867)
50. Huang SM, Lesko LJ,. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol 2004; 44: 559-69. (Pubitemid 38668017)
51. Ohnishi N, Yokoyama T,. Interactions between medicines and functional foods or dietary supplements. Keio J Med 2004; 53: 137-50. (Pubitemid 39318733)
52. Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB,. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med 2004; 164: 630-6. (Pubitemid 38392977)
53. Yin QP, Tomlinson B, Waye MM, Chow Albert HL, Chow Moses SS,. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004; 14: 841-50. (Pubitemid 40054339)
54. Yoshioka M, Ohnishi N, Koishi T, et al., Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biol Pharm Bull 2004; 27: 2006-9. (Pubitemid 41701579)
55. Bartlett H, Eperjesi F,. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthalmic Physiol Opt 2005; 25: 179-94. (Pubitemid 41702435)
56. Bressler R,. Herb-drug interactions: interactions between saw palmetto and prescription medications. Geriatrics 2005; 60: 32-4. (Pubitemid 41654250)
57. Bressler R,. Herb-drug interactions: interactions between kava and prescription medications. Geriatrics 2005; 60: 24-5. (Pubitemid 41318296)
58. Bressler R,. Herb-drug interactions: interactions between ginseng and prescription medications. Geriatrics 2005; 60: 16-7. (Pubitemid 41161304)
59. Bressler R,. Herb-drug interactions: St. John's wort and prescription medications. Geriatrics 2005; 60: 21-3. (Pubitemid 41022889)
60. Bressler R,. Herb-drug interactions: interactions between Ginkgo biloba and prescription medications. Geriatrics 2005; 60: 30-3. (Pubitemid 40529448)
61. Chiang HM, Fang SH, Wen KC, et al., Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats. Toxicol Appl Pharmacol 2005; 209: 263-8.
62. Gurley BJ, Gardner SF, Hubbard MA, et al., Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005; 22: 525-39. (Pubitemid 41003065)
63. Gurley BJ, Gardner SF, Hubbard MA, et al., In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005; 77: 415-26. (Pubitemid 40719269)
64. Hu Z, Yang X, Ho PCL, et al., Herb-drug interactions: a literature review. Drugs 2005; 65: 1239-82. (Pubitemid 41038418)
65. Izzo AA,. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005; 19: 1-16. (Pubitemid 40204343)
66. Izzo AA, Di Carlo G, Borrelli F, Ernst E,. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 2005; 98: 1-14. (Pubitemid 40169845)
67. Jan WC, Lin LC, Chen CF, Tsai TH,. Herb-drug interaction of Evodia rutaecarpa extract on the pharmacokinetics of theophylline in rats. J Ethnopharmacol 2005; 102: 440-5.
68. Marder VJ,. The interaction of dietary supplements with antithrombotic agents: scope of the problem. Thromb Res 2005; 117: 7-13. (Pubitemid 41597022)
69. Singh YN,. Potential for interaction of kava and St. John's wort with drugs. J Ethnopharmacol 2005; 100: 108-13. (Pubitemid 41073531)
70. Daugherty NE, Smith KM,. Dietary supplement and selected food interactions with warfarin. Orthopedics 2006; 29: 309-14.
71. Gurley BJ, Barone GW, Williams DK, et al., Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2006; 34: 69-74. (Pubitemid 43045694)
72. Haller CA,. Clinical approach to adverse events and interactions related to herbal and dietary supplements. Clin Toxicol (Phila) 2006; 44: 605-10.
73. Jiang X, Blair EY, McLachlan AJ,. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach. J Clin Pharmacol 2006; 46: 1370-8. (Pubitemid 44564366)
74. Meijerman I, Beijnen JH, Schellens JH,. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006; 11: 742-52. (Pubitemid 44157562)
75. Nutescu EA, Shapiro NL, Ibrahim S, West P,. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin Drug Saf 2006; 5: 433-51.
76. Venkataramanan R, Komoroski B, Strom S,. In vitro and in vivo assessment of herb drug interactions. Life Sci 2006; 78: 2105-15.
77. Yang XX, Hu ZP, Duan W, Zhu YZ, Zhou SF,. Drug-herb interactions: eliminating toxicity with hard drug design. Curr Pharm Des 2006; 12: 4649-64. (Pubitemid 44835152)
78. Gurley BJ, Swain A, Barone GW, et al., Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2007; 35: 240-5. (Pubitemid 46148736)
79. Marchetti S, Mazzanti R, Beijnen JH, Schellens JH,. Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist 2007; 12: 927-41. (Pubitemid 47359135)
80. Nekvindova J, Anzenbacher P,. Interactions of food and dietary supplements with drug metabolising cytochrome P450 enzymes. Ceska Slov Farm 2007; 56: 165-73. (Pubitemid 47475746)
81. Skalli S, Zaid A, Soulaymani R,. Drug interactions with herbal medicines. Ther Drug Monit 2007; 29: 679-86. (Pubitemid 350190846)
82. Sulli MM, Ezzo DC,. Drug interactions with vitamins and minerals. US Pharm 2007; 1: 42-55. (Pubitemid 351864109)
83. Tang J, Sun J, Zhang Y, Li L, Cui F, He Z,. Herb-drug interactions: effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats. Food Chem Toxicol 2007; 45: 2441-5. (Pubitemid 47600451)
84. Yetley EA,. Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions. Am J Clin Nutr 2007; 85: 269S-76S. (Pubitemid 46067647)
85. Cranwell-Bruce L,. Herb-drug interactions. Medsurg Nurs 2008; 17: 52-4.
86. Fan L, Zhang W, Guo D, et al., The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Ther 2008; 83: 471-6. (Pubitemid 351272636)
87. Gardiner P, Phillips R, Shaughnessy AF,. Herbal and dietary supplement-drug interactions in patients with chronic illnesses. Am Fam Physician 2008; 77: 73-8.
88. Gurley BJ, Swain A, Hubbard MA, et al., Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clin Pharmacol Ther 2008; 83: 61-9.
89. Gurley BJ, Swain A, Hubbard MA, et al., Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res 2008; 52: 755-63.
90. Gurley BJ, Swain A, Williams DK, Barone G, Battu SK,. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. Mol Nutr Food Res 2008; 52: 772-9.
91. Mohammed Abdul MI, Jiang X, Williams KM, et al., Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008; 154: 1691-700.
92. Nowack R,. Herb-drug interactions in nephrology: documented and theoretical. Clin Nephrol 2008; 69: 319-25. (Pubitemid 351663165)
93. Nowack R,. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort-and beyond! Nephrology (Carlton) 2008; 13: 337-47. (Pubitemid 351668338)
94. Okonta JM, Uboh M, Obonga WO,. Herb-drug interaction: a case study of effect of ginger on the pharmacokinetic of metronidazole in rabbit. Indian J Pharm Sci 2008; 70: 230-2. (Pubitemid 351920203)
95. Samuels N, Finkelstein Y, Singer SR, Oberbaum M,. Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008; 49: 373-80. (Pubitemid 351294530)
96. Sood A, Sood R, Brinker FJ, Mann R, Loehrer LL, Wahner-Roedler DL,. Potential for interactions between dietary supplements and prescription medications. Am J Med 2008; 121: 207-11. (Pubitemid 351317929)
97. Tomlinson B, Hu M, Lee VW,. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Mol Nutr Food Res 2008; 52: 799-809.
98. Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W, Woods J,. Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 2008; 9: 1063-120.
99. Borrelli F, Izzo AA,. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS J 2009; 11: 710-27.
100. Chang JC, Wu YT, Lee WC, Lin LC, Tsai TH,. Herb-drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats. Chem Biol Interact 2009; 182: 227-32.
101. Goldman RD, Vohra S, Rogovik AL,. Potential vitamin-drug interactions in children: at a pediatric emergency department. Paediatr Drugs 2009; 11: 251-7.
102. Holcomb SS,. Common herb-drug interactions: what you should know. Nurse Pract 2009; 34: 21-9.
103. Izzo AA, Ernst E,. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 2009; 69: 1777-98.
104. Lapi F, Vietri M, Moschlni M, et al., Definition of potential interactions between synthetic drugs, herbal drugs and dietary supplements during preoperative anaesthesiological assessment: a cross-sectional study in Tuscan County, Italy. Drug Saf 2009; 32: 982.
105. Shord SS, Shah K, Lukose A,. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther 2009; 8: 208-27.
106. Toselli F, Matthias A, Gillam EM,. Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine. Life Sci 2009; 85: 97-106.
107. Abad MJ, Bedoya LM, Bermejo P,. An update on drug interactions with the herbal medicine Ginkgo biloba. Curr Drug Metab 2010; 11: 171-81.
108. Cheng CW, Fan W, Ko SG, Song L, Bian ZX,. Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore (NY) 2010; 6: 324-9.
109. Chien CF, Wu YT, Lee WC, Lin LC, Tsai TH,. Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats. Chem Biol Interact 2010; 184: 458-65.
110. Kim BH, Kim KP, Lim KS, et al., Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Clin Ther 2010; 32: 380-90.
111. Nieminen TH, Hagelberg NM, Saari TI, et al., St John's wort greatly reduces the concentrations of oral oxycodone. Eur J Pain 2010; 14: 854-9.
112. Rogovik AL, Vohra S, Goldman RD,. Safety considerations and potential interactions of vitamins: should vitamins be considered drugs? Ann Pharmacother 2010; 44: 311-24.
113. Simmons T, Schneir AB,. Hypertensive crisis from a MAOI/Supplement interaction leading to myocardial infarction and acute heart failure. Clin Toxicol 2010; 48: 631.
114. Barnes PM, Powell-Griner E, McFann K, Nahin RL,. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1-19.
115. Barnes PM, Bloom B, Nahin RL,. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; 12: 1-23.
116. World Health Organization. WHO Monographs on Selected Medicinal Plants, Vol. 1. Geneva http://whqlibdoc.who.int/publications/1999/9241545178.pdf (accessed January 2012)
117. Barnes J, Anderson LA, Gibbons S, Phillipson JD,. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2005; 57: 929-54. (Pubitemid 41039828)
118. Sparreboom A, Cox MC, Acharya MR, Figg WD,. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22: 2489-503. (Pubitemid 41115408)
119. Howard N, Tsourounis C, Kapusnik-Uner J,. Dietary supplement survey of pharmacists: personal and professional practices. J Altern Complement Med 2001; 7: 667-80. (Pubitemid 34072582)
120. McHughes M, Timmermann BN,. A review of the use of CAM therapy and the sources of accurate and reliable information. J Manag Care Pharm 2005; 11: 695-703.
121. Vitry AI,. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 2007; 63: 709-14. (Pubitemid 46753565)